MBRX Award Disclosure
Klemp Walter V · SEC Form 4 · Filed Aug 5, 2026
Award
Reported value range
Not reported
Klemp Walter V CEO And President
MBRX
Transaction date
Aug 3, 2026
Public filing date
Aug 5, 2026
Filing lag
Filed 2 days later
MBRX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series I Warrants on Common Stock
- Quantity / price
- 1,599,999 shares
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001437749-26-025928
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moleculin Biotech, Inc. MBRX | Buy | Aug 3, 2026 | Not reported |
| Moleculin Biotech, Inc. MBRX Current | Award | Aug 3, 2026 | Not reported |